The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHome Reit Regulatory News (HOME)

  • This share is currently suspended. It was suspended at a price of 38.014

Share Price Information for Home Reit (HOME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.014
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 38.014
HOME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement regarding Home REIT plc

11 May 2023 16:56

RNS Number : 1596Z
Bluestar Group
11 May 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

For immediate release

11 May 2023

 

Statement regarding Home REIT PLC ("Home") by Bluestar Group Limited ("Bluestar")

Further to the announcement on 10 May 2023 by Bluestar made in relation to a possible offer for the entire issued and to be issued share capital of Home for 40 pence per share in cash (the "Possible Offer"), Bluestar today confirms it does not intend to make an offer under Rule 2.7 of the Code.

 

Bluestar is highly disappointed that the Board has not granted an extension to the PUSU deadline of 5.00 p.m. on 11 May 2023. Bluestar continues to believe that this Board decision removes a major element of optionality for shareholders and that the Possible Offer would have provided a route to upfront liquidity at a valuation level that Bluestar does not anticipate Home achieving in the public markets in the medium term.

 

This is a statement to which Rule 2.8 of the Code applies.

 

Under Note 2 on Rule 2.8 of the Code, Bluestar reserves the right to set the restrictions in Rule 2.8 aside in the following circumstances:

i) with the agreement of the Board;

ii) following the announcement of a firm intention to make an offer for Home by or on behalf of a third party;

iii) if Home announces a Rule 9 waiver (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); and

iv) where the Panel on Takeovers and Mergers has determined that there has been a material change of circumstances.

 

Enquiries:

Numis (Financial Adviser to Bluestar)

Hugh Jonathan +44 (0) 207 260 1000

Stuart Ord

 

Further information

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Bluestar and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Bluestar for providing the protections afforded to clients of Numis, nor for providing advice in relation to any matter referred to herein. Neither Numis nor any of its affiliates (nor any of their respective directors, officers, employees or agents), owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Numis in connection with this announcement, any statement contained herein or otherwise.

 

Ends

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPKZGMKKMFGFZM
Date   Source Headline
22nd Apr 20249:00 amRNSNotice of retail shareholder presentation
19th Apr 20247:00 amRNSProperty Sales
18th Apr 20247:00 amRNSUpdate on Potential Litigation
4th Apr 20247:00 amRNSMonthly Update
2nd Apr 20243:00 pmRNSDirectorate Change
28th Mar 20247:00 amRNSProperty Sales
5th Mar 20247:00 amRNSMonthly Update
29th Feb 20241:39 pmRNSResult of AGM
15th Feb 20247:00 amRNSProperty Sales
13th Feb 202411:00 amRNSNotification of Investigation by the FCA
5th Feb 20247:00 amRNSMonthly Update
1st Feb 202411:00 amRNSNotice of AGM
24th Jan 20247:00 amRNSProperty Sales
18th Jan 20247:00 amRNSDirectorate Change
16th Jan 20241:33 pmRNSHolding(s) in Company
15th Jan 20244:12 pmRNSHolding(s) in Company
15th Jan 20249:00 amRNSNotice of Retail Shareholder Presentation
8th Jan 20247:00 amRNSMonthly Update
20th Dec 20237:01 amRNSProperty Sales
20th Dec 20237:00 amRNSProperty Valuation and Portfolio Update
5th Dec 20237:00 amRNSMonthly Update
28th Nov 20237:00 amRNSSurrender of leases
9th Nov 20237:00 amRNSProperty Sales
6th Nov 20237:00 amRNSMonthly Update
12th Oct 20239:00 amRNSNotice of Retail Shareholder Presentation
2nd Oct 20237:00 amRNSMonthly Update
29th Sep 20237:00 amRNSProperty Sales
22nd Sep 20237:00 amRNSSurrender of leases and transfer of sub-leases
8th Sep 20233:16 pmRNSHolding(s) in Company
7th Sep 20235:03 pmRNSHolding(s) in Company
7th Sep 20237:00 amRNSTenant update
4th Sep 20237:00 amRNSMonthly Update
23rd Aug 20237:00 amRNSTransfer of sub-leases
21st Aug 20232:17 pmRNSResult of General Meeting
4th Aug 20237:00 amRNSProperty Sales
2nd Aug 20237:00 amRNSTenant update
28th Jul 20237:00 amRNSNotice of General Meeting
30th May 20237:00 amRNSUpdate on Internal Investigation
23rd May 20237:00 amRNSAppointment of AEW
15th May 20233:16 pmRNSHolding(s) in Company
11th May 20236:22 pmRNSResponse to announcement by Bluestar
11th May 20234:56 pmRNSStatement regarding Home REIT plc
10th May 20236:26 pmRNSUpdate regarding Possible Offer for Home REIT plc
2nd May 20232:33 pmRNSForm 8.3 - Home REIT PLC
2nd May 20237:00 amRNSForm 8.3 - Home REIT plc
28th Apr 20239:28 amRNSForm 8.3 - Home REIT PLC
26th Apr 20239:42 amRNSForm 8.3 - Home REIT PLC
24th Apr 202311:28 amRNSForm 8.3 - Home REIT PLC
19th Apr 20233:20 pmRNSForm 8.3 - Home REIT plc
19th Apr 20239:19 amRNSForm 8.3 - Home REIT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.